| clinical trial | Q30612 |
| P3098 | ClinicalTrials.gov ID | NCT00095784 |
| P6099 | clinical trial phase | phase II clinical trial | Q42824440 |
| P17 | country | United States of America | Q30 |
| P582 | end time | 2008-07-01 | |
| P1050 | medical condition | chronic idiopathic myelofibrosis | Q3857106 |
| P2899 | minimum age | 18 | |
| P1132 | number of participants | 21 | |
| P6153 | research site | Ohio State University | Q309331 |
| University of Chicago | Q131252 | ||
| Southern Illinois University Edwardsville | Q519349 | ||
| Ingalls Memorial Hospital | Q6031854 | ||
| Loyola University Medical Center | Q6694611 | ||
| Medical College of Wisconsin | Q6806307 | ||
| Decatur Memorial Hospital | Q22033932 | ||
| P580 | start time | 2004-09-29 | |
| P8363 | study type | interventional study | Q78089383 |
| P1476 | title | A Phase II Study of Decitabine in Myelofibrosis |
Search more.